NGAL Curve for the Early Diagnosis of AKI in Heart Failure Patients

  • C. Ronco
  • B. Noland
Part of the Annual Update in Intensive Care and Emergency Medicine book series (AUICEM, volume 2012)

Abstract

There has been increasing interest of clinicians in the high frequency of acute kidney injury (AKI) in acute heart failure (AHF). The most important mechanism behind cardiorenal syndrome type 1 is frequently an iatrogenic derangement caused by inappropriate use of diuretics or other strategies to alleviate congestion such as extracorporeal ultrafiltration [1]. In the attempt to remove fluid overload, severe hemodynamic consequences may lead to renal hypoperfusion and AKI.

Keywords

Acute Kidney Injury Heart Failure Patient Brain Natriuretic Peptide Acute Heart Failure Acute Decompensated Heart Failure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ronco C, McCullough PA, Anker SD, et al (2010) Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 165: 54–67PubMedCrossRefGoogle Scholar
  2. 2.
    Ronco C, Grammaticopoulos S, Rosner M, et al (2010) Oliguria, creatinine and other biomarkers of acute kidney injury. Contrib Nephrol 164: 118–127PubMedCrossRefGoogle Scholar
  3. 3.
    Coca SG, Yalavarthy R, Concato J, Parikh CR (2008) Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 73: 1008–1016PubMedCrossRefGoogle Scholar
  4. 4.
    Paragas N, Qiu A, Zhang Q, et al (2011) The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med 17: 216–222PubMedCrossRefGoogle Scholar
  5. 5.
    Koyner JL, Bennett MR, Worcester EM, et al (2008) Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int 74: 1059–1069PubMedCrossRefGoogle Scholar
  6. 6.
    Aghel A, Shrestha K, Mullens W, Borowski A, Tang WH (2010) Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure. J Card Fail 16: 49–54PubMedCrossRefGoogle Scholar
  7. 7.
    Nickolas TL, O’Rourke MJ, Yang J, et al (2008) Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 148: 810–819PubMedCrossRefGoogle Scholar
  8. 8.
    Alvelos M, Pimentel R, Pinho E, et al (2011) Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardiorenal syndrome in the general ward. Clin J Am Soc Nephrol 6: 476–481PubMedCrossRefGoogle Scholar
  9. 9.
    Kjeldsen L, Johnsen AH, Sengeløv H, Borregaard N (1993) Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268: 10425–10432PubMedGoogle Scholar
  10. 10.
    Flo TH, Smith KD, Sato S, et al (2004) Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432: 917–921PubMedCrossRefGoogle Scholar
  11. 11.
    Mishra J, Ma Q, Prada A, et al (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14: 2534–2543PubMedCrossRefGoogle Scholar
  12. 12.
    Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P (2004) Neutrophil gelatinaseassociated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 24: 307–315PubMedCrossRefGoogle Scholar
  13. 13.
    Mishra J, Dent C, Tarabishi R, et al (2005) Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365: 1231–1238PubMedCrossRefGoogle Scholar
  14. 14.
    Kusaka M, Kuroyanagi Y, Mori T, et al (2008) Serum neutrophil gelatinase-associated lipocalin as a predictor of organ recovery from delayed graft function after kidney transplantation from donors after cardiac death. Cell Transplant 17: 1–100CrossRefGoogle Scholar
  15. 15.
    Dent C, Ma Q, Dastrala S, et al (2007) Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 11: R127PubMedCrossRefGoogle Scholar
  16. 16.
    Zappitelli M, Washburn KK, Arikan AA, et al (2007) Urine neutrophil gelatinase associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care 11: R84PubMedCrossRefGoogle Scholar
  17. 17.
    Cruz DN, de Cal M, Garzotto F, et al (2010) Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 36: 444–451PubMedCrossRefGoogle Scholar
  18. 18.
    de Geus HR, Bakker J, Lesaffre EM, le Noble JL (2011) Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med 183: 907–914PubMedCrossRefGoogle Scholar
  19. 19.
    Shapiro NI, Trzeciak S, Hollander JE, et al (2010) The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis. Ann Emerg Med 56: 52–59PubMedCrossRefGoogle Scholar
  20. 20.
    Haase-Fielitz A, Bellomo R, Devarajan P, et al (2009) Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery—a prospective cohort study. Crit Care Med 37: 553–560PubMedCrossRefGoogle Scholar
  21. 21.
    Makris K, Markou N, Evodia E, et al (2009) Urinary neutrophil gelatinase-associated lipocalin (NGAL)as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med 47: 79–82PubMedCrossRefGoogle Scholar
  22. 22.
    Malyszko J, Bachorzewska-Gajewska H, Poniatowski B, Malyszko JS, Dobrzycki S (2009) Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. Renal Failure 31: 910–919PubMedCrossRefGoogle Scholar
  23. 23.
    Wasilewska A, Zoch-Zwierz W, Taranta-Janusz K, Michaluk-Skutnik J (2010) Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity? Pediatr Nephrol 25: 889–897PubMedCrossRefGoogle Scholar
  24. 24.
    Yilmaz A, Sevketoglu E, Gedikbasi A, et al (2009) Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin. Pediatr Nephrol 24: 2387–2392PubMedCrossRefGoogle Scholar
  25. 25.
    Bagshaw SM, Bennett M, Haase M, et al (2010) Plasma and urine neutrophil gelatinaseassociated lipocalin in septic versus non-septic acute kidney injury in critical illness Intensive Care Med 36: 452–461PubMedCrossRefGoogle Scholar
  26. 26.
    Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A; NGAL Meta-analysis Investigator Group (2009) Accuracy of neutrophil gelatinase-associated lipocalin (ngal) in diagnosis and prognosis in acute kidney injury: A systematic review and meta-analysis. Am J Kidney Dis 54: 1012–1024PubMedCrossRefGoogle Scholar
  27. 27.
    Damman K, Voors AA, Hillege HL, et al (2010) Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. Eur J Heart Fail 12: 974–982PubMedCrossRefGoogle Scholar
  28. 28.
    Valle R, Aspromonte N, Milani L, et al (2011) Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels. Heart Fail Rev 16: 519–529PubMedCrossRefGoogle Scholar
  29. 29.
    Gottlieb SS, Abraham W, Butler J, et al (2002) The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 8: 136–141PubMedCrossRefGoogle Scholar
  30. 30.
    Costanzo MR, Guglin ME, Saltzberg MT, et al (2007) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49: 675–683PubMedCrossRefGoogle Scholar
  31. 31.
    Cai L, Rubin J, Han W, Venge P, Xu S (2010) The origin of multiple molecular forms in urine of HNL/NGAL. Clin J Am Soc Nephrol 5: 2229–2235PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • C. Ronco
  • B. Noland

There are no affiliations available

Personalised recommendations